Officials have warned that the rise in Adderall prescriptions could be a sign of a future opioid-like epidemic. daily mail. The head of the Drug Enforcement Agency said the surge in new prescriptions could pose a high risk of abuse, similar to the opioid crisis.
For medicine, long list of serious side effects, anxiety, seizures, insomnia, hallucinations, psychosis, etc. There are also reports that this drug may contribute to symptoms such as: Increased risk of heart disease.
“I’m not trying to see the end of the world here…I feel like we’re standing on the precipice of the next drug crisis in the United States,” said Matthew Strait, assistant secretary for diversion management. . Department of the DEA.
The Daily Mail reported that prescriptions for Adderall have increased during the pandemic, which may be due to telemedicine companies. The number of prescriptions for this drug soared from 35.5 million in 2019 to 45 million in 2024.
The DEA is reportedly working to stop how much of the drug is manufactured and how many people have access to it. However, this does not yet address those who already have a valid prescription for the drug but are unable to obtain it.
“DEA has determined that the proposed APQs for amphetamine, lisdexamfetamine, and methylphenidate are sufficient to supply legitimate medical needs, reserve stocks, and 2024 export requirements.” . The agency wrote in its March filing..
but, CBS News reported Pharmaceutical companies have accused DEA quotas of hampering their ability to manufacture drugs to meet demand.
A spokesperson for Apotex, the maker of Vyvanse’s generic drug, said: “Restrictions on the production of the drug’s active ingredient are one of the main reasons why we are unable to fully supply the market.”
The report states that while a generic version of Vyvanse received FDA approval for the first time this year, nearly all recently approved manufacturers are now facing a shortage of lisdexamfetamine as they attempt to increase production. He said that
“We have used all of our allocation for calendar year 2023 as we do not have access to sufficient raw materials to commercialize this product on a full-scale commercial scale,” an Apotex spokesperson said.
It is estimated that one in four American teens abuses some type of prescription stimulant, such as Adderall. The CDC also reported that the percentage of children reported by their parents to have ADHD has steadily increased over time.
Do you like Blaze News? Avoid censorship and sign up for our newsletter to get articles like this delivered straight to your inbox. Register here!
